KALA BIO, Inc.

KALA · Nasdaq · SIC 2834: Pharmaceutical Preparations
183
SEC Filings

Business Summary

Part I Overview We are a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the front and back of the eye. Our product candidate, KPI-012, which we acquired from Combangio, Inc., or Combangio, on November 15, 2021, is a mesenchymal stem cell secretome, or MSC-S, and is currently in clinical development for the treatment of persistent corneal epithelial defects, or PCED, a rare disease of im...

Next Earnings

Q2 FY2026 — expected 2026-09-19

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionKALAdiscussed_in_filing Artificial Intelligence
topic_mentionKALAdiscussed_in_filing Cybersecurity
topic_mentionKALAdiscussed_in_filing Trusted Computing
topic_mentionKALAdiscussed_in_filing Blockchain & Crypto
topic_mentionKALAdiscussed_in_filing Capital Expenditure
topic_mentionKALAdiscussed_in_filing Regulation
topic_mentionKALAdiscussed_in_filing Automotive
topic_mentionKALAdiscussed_in_filing Healthcare & Bio
topic_mentionKALAdiscussed_in_filing Platform & Ecosystem
topic_mentionKALAdiscussed_in_filing Sovereign & Government
topic_mentionKALAdiscussed_in_filing Artificial Intelligence
topic_mentionKALAdiscussed_in_filing Cybersecurity
topic_mentionKALAdiscussed_in_filing Trusted Computing
topic_mentionKALAdiscussed_in_filing Blockchain & Crypto
topic_mentionKALAdiscussed_in_filing Capital Expenditure
topic_mentionKALAdiscussed_in_filing Regulation
topic_mentionKALAdiscussed_in_filing Automotive
topic_mentionKALAdiscussed_in_filing Healthcare & Bio
topic_mentionKALAdiscussed_in_filing Platform & Ecosystem
topic_mentionKALAdiscussed_in_filing Sovereign & Government

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-03-312024-12-310001558370-25-004081EDGAR138K words
2024-03-292023-12-310001558370-24-004326EDGAR—
2023-03-032022-12-310001558370-23-002746EDGAR—
2022-03-292021-12-310001558370-22-004624EDGAR—
2021-02-252020-12-310001558370-21-001797EDGAR—
2020-02-122019-12-310001558370-20-000733EDGAR—
2019-03-122018-12-310001558370-19-001825EDGAR—
2018-04-022017-12-310001558370-18-002697EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-192025-09-300001104659-25-113927EDGAR35K words
2025-08-082025-06-300001558370-25-010853EDGAR—
2025-05-142025-03-310001558370-25-007763EDGAR—
2024-11-122024-09-300001558370-24-015302EDGAR—
2024-08-062024-06-300001558370-24-011074EDGAR—
2024-05-142024-03-310001558370-24-008134EDGAR—
2023-11-132023-09-300001558370-23-018696EDGAR—
2023-08-042023-06-300001558370-23-013310EDGAR—
2023-05-092023-03-310001558370-23-008798EDGAR—
2022-11-082022-09-300001558370-22-016848EDGAR—
2022-08-112022-06-300001558370-22-013308EDGAR—
2022-05-162022-03-310001558370-22-008970EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-040001829126-26-001911EDGAR11K words
2026-02-200001829126-26-001534EDGAR—
2026-02-050001829126-26-000995EDGAR—
2026-02-020001829126-26-000837EDGAR—
2026-01-230001829126-26-000502EDGAR—
2026-01-080001829126-26-000110EDGAR—
2026-01-060001829126-26-000055EDGAR—
2026-01-020001829126-26-000023EDGAR—
2025-12-290001829126-25-010330EDGAR—
2025-12-160001829126-25-010045EDGAR—

183 total filings indexed. 153 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001479419
TickerKALA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 7e60cb7e50193a952ebd3795c5d73ec932bec088d11833fbe0dd222d8838a65a
parent: 7bd94b226ec75ca1b8ed0226345c8eaff491c3826400b158e4145d02e762a9aa
content hash: 2dae2796fbabb808e5368b10296c8947800d095b3640cf9bc0cfdf1a68ce2443
signed: 2026-04-13T04:45:51.150Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf